# Nek2 activation of Kif24 ensures cilium disassembly during the cell cycle

**Authors:** Sehyun Kim, Kwanwoo Lee, Jung-Hwan Choi, Niels Ringstad, Brian David Dynlacht

PMC · DOI: 10.1038/ncomms9087 · Nature communications · 2016-02-20

## TL;DR

This paper reveals how the proteins Nek2 and Kif24 work together to break down cell structures called cilia before cells divide, and how this process is linked to cancer cell growth.

## Contribution

The study identifies Kif24 as a new physiological substrate of Nek2, revealing a novel mechanism for cilium disassembly during the cell cycle.

## Key findings

- Nek2 phosphorylates Kif24, enhancing its activity to prevent cilia formation.
- Nek2 and Kif24 promote cilium disassembly independently of Aurora A and HDAC6.
- Overexpression of Nek2 and Kif24 in breast cancer cells reduces ciliation and proliferation.

## Abstract

Many proteins are known to promote ciliogenesis, but mechanisms that promote primary cilia disassembly prior to mitosis are largely unknown. Here, we identify a mechanism that favors cilium disassembly and maintains the disassembled state. We show that co-localization of the S/G2 phase kinase, Nek2, and Kif24 triggers Kif24 phosphorylation, inhibiting cilia formation. We show that Kif24, a microtubule depolymerizing kinesin, is phosphorylated by Nek2, which stimulates its activity and prevents the outgrowth of cilia in proliferating cells, independent of Aurora A and HDAC6. Our data also suggest that cilium assembly and disassembly are in dynamic equilibrium, but Nek2 and Kif24 can shift the balance toward disassembly. Further, Nek2 and Kif24 are over-expressed in breast cancer cells, and ablation of these proteins restores ciliation in these cells, thereby reducing proliferation. Thus, Kif24 is a physiological substrate of Nek2, which regulates cilia disassembly through a concerted mechanism involving Kif24-mediated microtubule de-polymerization.

## Linked entities

- **Genes:** NEK2 (NIMA related kinase 2) [NCBI Gene 4751], KIF24 (kinesin family member 24) [NCBI Gene 347240], Aurora-A (hypothetical protein) [NCBI Gene 7200473], HDAC6 (histone deacetylase 6) [NCBI Gene 10013]
- **Proteins:** NEK2 (NIMA related kinase 2), KIF24 (kinesin family member 24), Aurora-A (hypothetical protein), HDAC6 (histone deacetylase 6)
- **Diseases:** breast cancer (MONDO:0004989)

## Full-text entities

- **Genes:** GSTK1 (glutathione S-transferase kappa 1) [NCBI Gene 373156] {aka GST, GST 13-13, GST13, GST13-13, GSTK1-1, hGSTK1}, MYC (MYC proto-oncogene, bHLH transcription factor) [NCBI Gene 4609] {aka MRTL, MYCC, bHLHe39, c-Myc}, POTEF (POTE ankyrin domain family member F) [NCBI Gene 728378] {aka A26C1B, POTE2alpha, POTEACTIN}, SASS6 (SAS-6 centriolar assembly protein) [NCBI Gene 163786] {aka MCPH14, SAS-6, SAS6}, CNKSR2 (connector enhancer of kinase suppressor of Ras 2) [NCBI Gene 22866] {aka CNK2, KSR2, MAGUIN, MRXSHG}, MYH14 (myosin heavy chain 14) [NCBI Gene 79784] {aka DFNA4, DFNA4A, FP17425, MHC16, MYH17, NMHC II-C}, KIAA0586 (KIAA0586) [NCBI Gene 9786] {aka JBTS23, SRTD14, Talpid3}, Mki67 (antigen identified by monoclonal antibody Ki 67) [NCBI Gene 17345] {aka D630048A14Rik, Ki-67, Ki67}, TUBA1B (tubulin alpha 1b) [NCBI Gene 10376] {aka K-ALPHA-1}, KIF2C (kinesin family member 2C) [NCBI Gene 11004] {aka CT139, KNSL6, MCAK}, FANCB (FA complementation group B) [NCBI Gene 2187] {aka FA2, FAAP90, FAAP95, FAB, FACB}, AURKB (aurora kinase B) [NCBI Gene 9212] {aka AIK2, AIM-1, AIM1, ARK-2, ARK2, AurB}, ARL13B (ARF like GTPase 13B) [NCBI Gene 200894] {aka ARL2L1, JBTS8}, KIF24 (kinesin family member 24) [NCBI Gene 347240] {aka C9orf48, bA571F15.4}, CETN2 (centrin 2) [NCBI Gene 1069] {aka CALT, CEN2}, CXCL14 (C-X-C motif chemokine ligand 14) [NCBI Gene 9547] {aka BMAC, BRAK, KEC, KS1, MIP-2g, MIP2G}, CPAP (centrosome assembly and centriole elongation protein) [NCBI Gene 55835] {aka BM032, CENP-J, CENPJ, LAP, LIP1, MCPH6}, IFT88 (intraflagellar transport 88) [NCBI Gene 8100] {aka D13S1056E, DAF19, TG737, TTC10, hTg737}, HDAC6 (histone deacetylase 6) [NCBI Gene 10013] {aka CPBHM, HD6, JM21, KDAC6, PPP1R90}, KIF2A (kinesin family member 2A) [NCBI Gene 3796] {aka CDCBM3, HK2, KIF2}, NEDD9 (neural precursor cell expressed, developmentally down-regulated 9) [NCBI Gene 4739] {aka CAS-L, CAS2, CASL, CASS2, HEF1}, GATD3 (glutamine amidotransferase class 1 domain containing 3) [NCBI Gene 8209] {aka C21orf33, ES1, GATD3A, GATD3B, GT335, HES1}, CEP97 (centrosomal protein 97) [NCBI Gene 79598] {aka 2810403B08Rik, LRRIQ2}, PLK1 (polo like kinase 1) [NCBI Gene 5347] {aka PLK, STPK13}, CCNA2 (cyclin A2) [NCBI Gene 890] {aka CCN1, CCNA}, NEK2 (NIMA related kinase 2) [NCBI Gene 4751] {aka HsPK21, NEK2A, NLK1, PPP1R111, RP67}, CEP164 (centrosomal protein 164) [NCBI Gene 22897] {aka NPHP15}, Nek2 (NIMA (never in mitosis gene a)-related expressed kinase 2) [NCBI Gene 18005], AURKA (aurora kinase A) [NCBI Gene 6790] {aka AIK, ARK1, AURA, BTAK, PPP1R47, STK15}, HRAS (HRas proto-oncogene, GTPase) [NCBI Gene 3265] {aka C-BAS/HAS, C-H-RAS, C-HA-RAS1, CTLO, H-RASIDX, HAMSV}, SPINK5 (serine peptidase inhibitor Kazal type 5) [NCBI Gene 11005] {aka LEKTI, LETKI, NETS, NS, VAKTI}, Kif24 (kinesin family member 24) [NCBI Gene 313170] {aka RGD1307723}
- **Diseases:** obesity (MESH:D009765), triple-negative breast cancers (MESH:D064726), ciliary dysfunction (MESH:D002925), mammary tumorigenesis (MESH:D063646), ciliopathies (MESH:D000072661), metastatic carcinoma (MESH:C538445), developmental defects (MESH:D000094602), viral infection (MESH:D014777), Cancer (MESH:D009369), breast, pancreatic and prostatic tumours (MESH:D011471), polycystic kidney disease (MESH:D007690), Breast cancers (MESH:D001943), comedo-type ductal carcinoma in situ (MESH:D002285), Defects in (MESH:D000013)
- **Chemicals:** F-12 (MESH:C007782), DTT (MESH:D004229), Lipofectamine (MESH:C086724), MnCl2 (MESH:C025340), Hepes (MESH:D006531), MgCl2 (MESH:D015636), 4,6-diamidino-2-phenylindole (MESH:C007293), ethylene glycol tetraacetic acid (MESH:D004533), glutathione (MESH:D005978), agarose (MESH:D012685), NaF (MESH:D012969), glycerol (MESH:D005990), formalin (MESH:D005557), 4-(2-aminoethyl)benzenesulfonyl fluoride hydrochloride (MESH:C002010), E1A lysis buffer (-), thymidine (MESH:D013936), Coomassie blue (MESH:C048139), PHA-680632 (MESH:C524543), PIPES (MESH:C008916), ATP (MESH:D000255), beta-glycerol phosphate (MESH:C031463), PBS (MESH:D007854), hydrocortisone (MESH:D006854), Tubacin (MESH:C474316), NaCl (MESH:D012965), Taxol (MESH:D017239), Flag peptide (MESH:C085706), dimethylsulphoxide (MESH:D004121), Triton X-100 (MESH:D017830), AlexaFluor488- (MESH:C000711379), SDS (MESH:D012967), NP-40 (MESH:C010615), EDTA (MESH:D004492), puromycin (MESH:D011691), methanol (MESH:D000432)
- **Species:** Chlamydomonas (genus) [taxon 3052], Mus musculus (house mouse, species) [taxon 10090], Giardia (genus) [taxon 5740], Felis catus (cat, species) [taxon 9685], Tetrahymena (genus) [taxon 5890], Homo sapiens (human, species) [taxon 9606], Hydra (genus) [taxon 6083]
- **Mutations:** T240-A, T621D, Ser-to-Ala, serine/threonine, V12G, T621A, S789A, S622, T621, S810A, S622A, S622D
- **Cell lines:** MDA-MB-231 — Homo sapiens (Human), Breast adenocarcinoma, Cancer cell line (CVCL_0062), ZR57-1 — Homo sapiens (Human), Invasive breast carcinoma of no special type, Cancer cell line (CVCL_0588), MCF10AT1 — Homo sapiens (Human), Spontaneously immortalized cell line (CVCL_WM99), DCIS.com — Homo sapiens (Human), Transformed cell line (CVCL_5552), MCF10CA1 — Homo sapiens (Human), Transformed cell line (CVCL_6675), Sf9 — Spodoptera frugiperda (Fall armyworm), Spontaneously immortalized cell line (CVCL_0549), pLVX — Homo sapiens (Human), Spontaneously immortalized cell line (CVCL_B0BB), insect — Trichoplusia ni (Cabbage looper), Spontaneously immortalized cell line (CVCL_C190), MCF10 — Homo sapiens (Human), Spontaneously immortalized cell line (CVCL_0598), RPE1 — Homo sapiens (Human), Telomerase immortalized cell line (CVCL_4388), CA1 — Homo sapiens (Human), Head and neck squamous cell carcinoma, Cancer cell line (CVCL_A5TQ), MDA-MB-468 — Homo sapiens (Human), Breast adenocarcinoma, Cancer cell line (CVCL_0419), Hs578T — Homo sapiens (Human), Invasive breast carcinoma of no special type, Cancer cell line (CVCL_0332), MCF7 — Homo sapiens (Human), Invasive breast carcinoma of no special type, Cancer cell line (CVCL_0031), TS-A — Mus musculus (Mouse), Malignant neoplasms of the mouse mammary gland, Cancer cell line (CVCL_F736), U2OS — Homo sapiens (Human), Osteosarcoma, Cancer cell line (CVCL_0042), -C — Mus musculus (Mouse), Finite cell line (CVCL_S361), HMEC — Homo sapiens (Human), Transformed cell line (CVCL_Y905), pigment — Homo sapiens (Human), Spontaneously immortalized cell line (CVCL_IQ82), AT1 — Mus musculus (Mouse), Hybridoma (CVCL_C7RB), HEK293 — Homo sapiens (Human), Transformed cell line (CVCL_0045)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC4545512/full.md

## Figures

7 figures with captions in the complete paper: https://tomesphere.com/paper/PMC4545512/full.md

## References

52 references — full list in the complete paper: https://tomesphere.com/paper/PMC4545512/full.md

---
Source: https://tomesphere.com/paper/PMC4545512